Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALLEGRO-2b/3: Ritlecitinib in Alopecia Areata
NCT03732807Phase 3Completed
- Sponsor
- Pfizer
- Start
- Dec 2018
- Primary completion
- Dec 2020
- Modality
- Small Molecules
- Countries
- 18
01
Overview
A Phase 3 trial of ritlecitinib tosilate in alopecia areata, sponsored by Pfizer. Started Dec 2018; status: completed.
02
Drugs
ritlecitinib tosilate
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT03732807.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03732807.